Feature Avivagen shifts to commercial mindset from R&D By Len Zehr Cameron Groome, who moved into the executive suite at Avivagen (TSX-V:VIV) in March, has transformed the focus of the animal wellness company to a business and product development engine and away from an... June 18, 2013